SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 601–700 of 1,001
DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
Booiman, T., Loukachov, V. V., van Dort, K. A., Wout, A. B. V. ’., & Kootstra, N. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144229 · Cited by 28
“On the other hand, a number of host factors, such as MX2 [10–12], TRIM5α [13,14], SAMHD1 [15,16], APOBEC3 [17–19] and Tetherin [20] have been described to display antiviral effects and restrict viral replication.”
BackgroundSoliman, M., Srikrishna, G., & Balagopal, A. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0357-9 · Cited by 30
HIV-1 Vpr and p21 restrict LINE-1 mobility
Kawano, K., Doucet, A. J., Ueno, M., Kariya, R., An, W., Marzetta, F., Kuroki, M., Turelli, P., Sukegawa, S., Okada, S., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky688 · Cited by 29
Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction
Slavkovic‐Lukic, D., Hotz‐Wagenblatt, A., Lei-Rossmann, J., Räthe, A.-M., Muhle, M. E., Denner, J., Münk, C., & Löchelt, M. (2013) · Retrovirology · doi:10.1186/1742-4690-10-76 · Cited by 28
“; licensee BioMed Creative Commons Attribution License (http:/ distribution, and reproduction in any medium characterized in detail: APOBEC3, Trim5α, tetherin and SAMHD1 [8-12].”
InfluentialCharacterisation of assembly and ubiquitylation by the RBCC motif of Trim5α
Keown, J. R., Yang, J. X., Douglas, J., & Goldstone, D. C. (2016) · Scientific Reports · doi:10.1038/srep26837 · Cited by 30
Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV
Wilkins, J. M., Zheng, Y.-M., Yu, J., Liang, C., & Liu, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156739 · Cited by 31
“Several ISGs have been characterized with antiviral activity, including Tetherin, TRIM5α, APOBEC3G, SAMHD1, and MxB [4] [5] [6] [7] [8] [9] [10] [11] .”
Cloherty, A. P. M., Rader, A. G., Compeer, B., & Ribeiro, C. M. S. (2021) · Viruses · doi:10.3390/v13020320 · Cited by 31
“In support of this, pre-treatment with Vpx, a known inducer of SAMHD1 degradation during HIV-2 or SIV infection but absent in HIV-1, promoted degradation of SAMHD1 and enhanced susceptibility of macrophages and DCs to HIV-1 [35].”
He, T., Dang, L., Zhang, J., Zhang, J., Wang, G., Wang, E., Xia, H., Zhou, W., Wu, S., & Liu, X. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00849-1 · Cited by 28
“Primary MDMs were treated with either LATS2-shRNA lentivirus or scramble shRNA lentivirus for 24 h, then infected with VSV-G pseudotyped HIV-1 virus and VLP-VPX for 20 h as described in the literature [39, 63, 64].”
MethodPersistent Inflammation and Non-AIDS Comorbidities During ART: Coming of the Age of Monocytes
Bai, R., Li, Z., Lv, S., Wang, R., Hua, W., Wu, H., & Dai, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.820480 · Cited by 29
Molecular Mechanisms of HIV Immune Evasion of the Innate Immune Response in Myeloid Cells
Mashiba, M., & Collins, K. L. (2012) · Viruses · doi:10.3390/v5010001 · Cited by 29
“Based on these data, SAMHD1 is necessary and sufficient to inhibit infection of myeloid cells and quiescent CD4 + T cells by lentiviruses not expressing Vpx [38,39].”
BackgroundMethodInfluentialSIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS
Westmoreland, S. V., Converse, A. P., Hrecka, K., Hurley, M., Knight, H., Piatak, M., Lifson, J. D., Mansfield, K. G., Skowroński, J., & Desrosiers, R. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084463 · Cited by 27
“This is interesting in light of the recent revelation that Vpx targets SAMHD1 for degradation [12–14], resulting in increased available dNTPs in macrophages and dendritic cells as substrates for lentiviral replication [8,9].”
BackgroundMacaques as model hosts for studies of HIV-1 infection
Misra, A., Thippeshappa, R., & Kimata, J. T. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00176 · Cited by 28
Innate immune defects in HIV permissive cell lines
Rausell, A., Muñoz, M., Martínez, R., Roger, T., Telenti, A., & Ciuffi, A. (2016) · Retrovirology · doi:10.1186/s12977-016-0275-8 · Cited by 29
“org and [19, 22–28]).”
Jang, S., Zhou, X., & Ahn, J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00627 · Cited by 27
“Mutation of catalytic residues or knock-down of SAMHD1 results in enhanced HIV-1 replication (32).”
BackgroundPIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation
Miyakawa, K., Matsunaga, S., Yokoyama, M., Nomaguchi, M., Kimura, Y., Nishi, M., Kimura, H., Sato, H., Hirano, H., Tamura, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09867-7 · Cited by 27
Cell Cycle Regulation in Macrophages and Susceptibility to HIV-1
Ferreira, I. A. T. M., Porterfield, J. Z., Gupta, R. K., & Mlčochová, P. (2020) · Viruses · doi:10.3390/v12080839 · Cited by 27
Aljawai, Y. M., Richards, M. H., Seaton, M., Narasipura, S. D., & Al‐Harthi, L. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526122249 · Cited by 27
“Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature.”
BackgroundOdegard, J. M., Kelley-Clarke, B., Tareen, S. U., Campbell, D. J., Flynn, P. A., Nicolai, C. J., Slough, M. M., Vin, C. D., McGowan, P. J., Nelson, L. T., et al. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000067 · Cited by 26
Viral and cellular mechanisms of the innate immune sensing of HIV
Lahaye, X., & Manel, N. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.01.013 · Cited by 26
Kohnken, R. A., Kodigepalli, K. M., Mishra, A., Porcu, P., & Wu, L. J. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.11.010 · Cited by 26
The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block
Rihn, S. J., Foster, T. L., Busnadiego, I., Aziz, M. A., Hughes, J., Neil, S. J. D., & Wilson, S. J. (2017) · Journal of Virology · doi:10.1128/jvi.02254-16 · Cited by 26
Tetraspanins, Another Piece in the HIV-1 Replication Puzzle
Suárez, H., Rocha‐Perugini, V., Álvarez, S., & Yáñez‐Mó, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01811 · Cited by 26
“HIV-2 virus, but not HIV-1, expresses an accessory protein called Vpx that tags SAMHD1 for its degradation by the proteasome (93, 101).”
BackgroundGeneration of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
Comi, M., Amodio, G., Passeri, L., Fortunato, M., de Sio, F. R. S., Andolfi, G., Kajaste‐Rudnitski, A., Russo, F., Cesana, L., & Gregori, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01260 · Cited by 26
HIV Latency in Myeloid Cells: Challenges for a Cure
Chitrakar, A., Sanz, M., Maggirwar, S. B., & Soriano-Sarabia, N. (2022) · Pathogens · doi:10.3390/pathogens11060611 · Cited by 29
“These restriction factors are proteins that provide an initial line of defense against HIV infection [74,75].”
BackgroundRole of macrophages in HIV pathogenesis and cure: NIH perspectives
Joseph, J., Daley, W., Lawrence, D. M. P., Lorenzo, E., Perrin, P., Rao, V. R., Tsai, S., & Varthakavi, V. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0722-619r · Cited by 28
The role of O-GlcNAcylation in innate immunity and inflammation
Wang, Y., Fang, X., Wang, S., Wang, B., Chu, F., Tian, Z., Zhang, L., & Zhou, F. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac065 · Cited by 30
“…HIV-1 ) , herpes simplex virus 1 ( HSV-1 ) , hepatitis B virus ( HBV ) , and vaccinia virus by regulating the levels of deoxynucleoside triphosphates ( dNTPs ) in non-cycling cells ( Hrecka et al., 2011 ; Laguette et al., 2011 ; Hollenbaugh et al., 2013 ; Kim et al., 2013 ; Sommer et al., 2016 ) .”
Li, Y., Gao, Y., Jiang, X., Cheng, Y., Zhang, J., Xu, L., Liu, X., Huang, Z., Xie, C., & Gong, Y. Q. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03844-3 · Cited by 30
“In the past decade, consequent researches revealed that SAMHD1 was a key limiting factor for human immunodeficiency virus infection [11], and that its mutation caused Aicardi–Goutières syndrome, a hereditary inflammatory encephalopathy caused by excessive interferon (IFN) production [12].”
BackgroundRole of Glycosphingolipids in Dendritic Cell-Mediated HIV-1 Trans-infection
Puryear, W. B., & Gummuluru, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_5 · Cited by 28
“Recent studies have defined the molecular details of one such restriction mechanism that blocks HIV-1 infection of DCs at an early step in the viral life cycle (Hrecka et al. 2011; Laguette et al. 2011).”
BackgroundBehrendt, R., & Roers, A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12147 · Cited by 27
Gavegnano, C., Kennedy, E. M., Kim, B., & Schinazi, R. F. (2012) · Molecular Biology International · doi:10.1155/2012/625983 · Cited by 26
“Recent reports have identified the sterile alpha motif (SAM) domain and HD domain-containing protein 1 (SAMHD1) protein, which is encoded by the SAMHD1 gene, as a cellular factor that regulates cell-specific restriction of HIV-1 replication in cells of the myeloid lineage [20, 30, 31].”
BackgroundForlani, G., Abdallah, R., Accolla, R. S., & Tosi, G. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00234 · Cited by 27
“They include host-encoded restriction factors, initially described for their inhibitory effect on immunodeficiency virus type 1 (HIV-1) infection (reviewed in Wolf and Goff, 2008), such as apolipoprotein B mRNA-editing catalytic polypeptides (APOBECs; Sheehy et al., 2002; Chiu and Greene, 2008; Refsland and Harris, 20…”
BackgroundDiscovery of Novel Ribonucleoside Analogs with Activity against Human Immunodeficiency Virus Type 1
Dapp, M. J., Bonnac, L. F., Patterson, S. E., & Mansky, L. M. (2013) · Journal of Virology · doi:10.1128/jvi.02444-13 · Cited by 26
“, APOBEC3G, SamHD1) that target viral DNA synthesis have been discovered (3, 4).”
BackgroundInnate Antiviral Defenses Independent of Inducible IFNα/β Production
Paludan, S. R. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.003 · Cited by 29
Hamimi, C., David, A., Versmisse, P., Weiss, L., Bruel, T., Zucman, D., Appay, V., Moris, A., Ungeheuer, M., Lascoux‐Combe, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160251 · Cited by 26
“This restriction is related, in part, to the antiviral activity of SAMHD-1 that degrades the cellular dNTP pool [18, 19], crucial for HIV reverse transcription, and viral nucleic acids [20].”
Shingai, M., Welbourn, S., Brenchley, J. M., Acharya, P., Miyagi, E., Plishka, R. J., Buckler-White, A. J., Kwong, P. D., Nishimura, Y., Strebel, K., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004928 · Cited by 26
“…replication kinetics in human SupT1-R5 cells indistinguishable from corresponding WT viruses (Fig 2E and 2F), consistent with results reporting that SupT1-R5 cells do not express the SAMHD1 protein [8], and confirming the absence of any inherent replication defects in these mutant viruses.”
Snapin promotes HIV‐1 transmission from dendritic cells by dampening TLR8 signaling
Khatamzas, E., Hipp, M., Gaughan, D., Pichulik, T., Leslie, A. J., Fernandes, R. A., Muraro, D., Booth, S., Zausmer, K., Sun, M., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695364 · Cited by 26
“Within the cytosol, HIV-1 encounters the deoxyribose nucleoside triphosphate hydrolase SAMHD1, which limits the efficiency of HIV reverse transcription and inhibits replication (Goldstone et al , 2011; Hrecka et al , 2011; Laguette et al , 2011).”
Zhang, Y., Ozono, S., Yao, W., Tobiume, M., Yamaoka, S., Kishigami, S., Fujita, H., & Tokunaga, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40003-z · Cited by 28
Role of Divalent Cations in HIV-1 Replication and Pathogenicity
Khan, N., Chen, X., & Geiger, J. D. (2020) · Viruses · doi:10.3390/v12040471 · Cited by 27
Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis
Lubow, J., & Collins, K. L. (2020) · Viruses · doi:10.3390/v12080809 · Cited by 30
Evolutionary conflicts and adverse effects of antiviral factors
Sauter, D., & Kirchhoff, F. (2021) · eLife · doi:10.7554/elife.65243 · Cited by 26
Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains
Li, W., Gorantla, S., Gendelman, H. E., & Poluektova, L. Y. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.031773 · Cited by 27
“…the IFI and IFIT family, are involved in combating viruses at nearly every stage of the viral life cycle (Espert et al., 2005; Fricke et al., 2014; Laguette et al., 2011; Lu et al., 2011; Nasr et al., 2012; Neil et al., 2008; Okumura et al., 2006; Rivieccio et al., 2006; Spragg and Emerman, 2013).”
Mechanisms of Immune Evasion in HIV-1: The Role of Virus-Host Protein Interactions
Mouzakis, A., Petrakis, V., Tryfonopoulou, E., Panopoulou, M. I., Panagopoulos, P., & Chlichlia, K. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47050367 · Cited by 26
“Leads SAMHD1 to proteasomal degradation [87] STING Interacts with STING and inhibits the activation of NF-κ B [90] HUSH Promotes the degradation of HUSH, enabling viral gene expression [91] All the interactions described in Sections 2.1–2.6 are presented in Figure 2 as a schematic representation.”
InfluentialNew power in cancer immunotherapy: the rise of chimeric antigen receptor macrophage (CAR-M)
Jing, J., Chen, Y., Chi, E., Li, S., He, Y., Wang, B., Shen, H., Fan, L., Wang, J., Shangguan, T., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07115-9 · Cited by 27
“It effectively enhances the transduction efficiency of the HIV-1 derived lentiviral vector in myeloid cells by targeting and degrading the SAMHD1 protein [36, 37].”
Lenzi, G. M., Domaoal, R. A., Kim, D., Schinazi, R. F., & Kim, B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691576 · Cited by 25
“Based on the findings that SAMHD1 mediates the dNTP depletion of macrophages, we reasoned that Vpx coding HIV2/SIV replicate under increased dNTP conditions even in nondividing cells by counteracting SAMHD1.”
BackgroundInfluentialTRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling
Espada, C. E., Gelais, C. S., Bonifati, S., Maksimova, V. V., Cahill, M. P., Kim, S. H., & Wu, L. J. (2020) · Journal of Virology · doi:10.1128/jvi.01970-20 · Cited by 25
“1 (HIV-1) infection in non-dividing cells of myeloid lineage (1, 2) and resting CD4+ T cells (3, 4).”
BackgroundRegulation of Viral Restriction by Post-Translational Modifications
Chamontin, C., Bossis, G., Nisole, S., Arhel, N. J., & Maarifi, G. (2021) · Viruses · doi:10.3390/v13112197 · Cited by 28
“Since, a variety of additional restriction factors have been described such as TRIM5α [5,6], APOBEC3G [7–9], SAMHD1 [10,11], Mx2/MxB [12–14], Tetherin/BST2 [15,16], SERINC3/5 [17,18] and IFITMs [19].”
BackgroundNeuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity
Wang, S., Zhao, L., Zhang, X., Zhang, J., Shang, H., & Liang, G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114884119 · Cited by 25
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
Allouch, A., Voisin, L., Zhang, Y., Raza, S. Q., Lécluse, Y., Calvo, J., Selimoglu‐Buet, D., de Botton, S., Louache, F., Pflumio, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34548-3 · Cited by 29
Münk, C., Jensen, B. O., Zielonka, J., Häussinger, D., & Kamp, C. (2012) · Viruses · doi:10.3390/v4113132 · Cited by 26
“While in HIV-1 no protein evolved to inhibit SAMHD1, the related HIV-2 uses its Vpx protein to destroy this dNTPase [15–17].”
BackgroundЧерешнев, В. А., Bocharov, G. A., Bazhan, S. I., Bachmetyev, B. A., Gainova, I., Likhoshvai, V. A., Argilaguet, J. M., Martínez, J. P., Rump, J. A., Mothe, B., et al. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.779375 · Cited by 28
“[59] Laguette N, Sobhian B, Casartelli N, et al.”
BackgroundCavaleiro, R., Rego, R. T., Foxall, R. B., Soares, R. S., Baptista, A. P., Gómes, P., Valadas, E., Victorino, R. M. M., & Sousa, A. E. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit085 · Cited by 25
Yu, H., Usmani, S. M., Borch, A., Krämer, J., Stürzel, C., Khalid, M., Li, X., Krnavek, D., van der Ende, M. E., Osterhaus, A., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-27 · Cited by 27
“In contrast, HIV-1 and its direct simian counterpart (SIVcpz infecting chimpanzees) do not encode Vpx [15] and the HIV-1 Vpr protein does apparently not counteract SAMHD1-mediated restriction [3,4].”
BackgroundMethodResultInfluentialTargeted, homology-driven gene insertion in stem cells by ZFN-loaded ‘all-in-one’ lentiviral vectors
Cai, Y., Laustsen, A., Zhou, Y., Sun, C., Anderson, M. V., Li, S., Uldbjerg, N., Luo, Y., Jakobsen, M. R., & Mikkelsen, J. G. (2016) · eLife · doi:10.7554/elife.12213 · Cited by 26
Wang, Z., Bhattacharya, A., Villacorta, J., Diaz‐Griffero, F., & Ivanov, D. N. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.c116.751446 · Cited by 25
SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV
González-Enríquez, G. V., Escoto-Delgadillo, M., Vázquez-Valls, E., & Torres-Mendoza, B. M. (2017) · Journal of Immunology Research · doi:10.1155/2017/1548905 · Cited by 29
Gelais, C. S., Kim, S., Maksimova, V. V., Buzovetsky, O., Knecht, K. M., Shepard, C., Kim, B., Xiong, Y., & Wu, L. J. (2018) · Journal of Virology · doi:10.1128/jvi.01787-17 · Cited by 27
“SIV, encode the Vpx protein, which targets SAMHD1 for proteasomal degradation (4, 5).”
BackgroundMethodde Pablo-Maiso, L., Doménech, A., Echeverría, I., Gómez-Arrebola, C., de Andrés, D., Rosati, S., Gómez‐Lucía, E., & Reina, R. (2018) · Viruses · doi:10.3390/v10080435 · Cited by 28
“Recently, the human protein SAMHD1 has been identified to be causative for the post-entry restriction of HIV-1 in myeloid cells [183,184].”
BackgroundWidera, M., Hillebrand, F., Erkelenz, S., Vasudevan, A. A. J., Münk, C., & Schaal, H. (2014) · Retrovirology · doi:10.1186/preaccept-1252941606128392 · Cited by 25
Cyclin-dependent kinases as therapeutic targets for HIV-1 infection
Rice, A. P. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1254619 · Cited by 25
“quently identified to be a phosphohydrolase named SAMHD1 that cleaves dNTPs into deoxynucleotides and inorganic triphosphates [39,40].”
BackgroundLiang, G., Zhao, L., Qiao, Y., Geng, W., Zhang, X., Liu, M., Dong, J., Ding, H., Sun, H., & Shang, H. (2019) · Nature Immunology · doi:10.1038/s41590-019-0385-2 · Cited by 24
Brinckmann, S., da Costa, K., van Gils, M. J., Hallengärd, D., Klein, K., Madeira, L. M., Mainetti, L., Palma, P., Raue, K., Reinhart, D., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-40 · Cited by 25
Wang, F., Gelais, C. S., de Silva, S., Zhang, H., Geng, Y., Shepard, C., Kim, B., Yount, J. S., & Wu, L. J. (2015) · Virology · doi:10.1016/j.virol.2015.10.024 · Cited by 27
“For HIV-1 luc/VSV-G infection, U937 cells were treated with PMA and differentiated into non-dividing, macrophage-like cells (Laguette et al., 2011a).”
Ryoo, J., Hwang, S.-Y., Choi, J., Oh, C., & Ahn, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.013 · Cited by 28
A viral kinase counteracts in vivo restriction of murine cytomegalovirus by SAMHD1
Deutschmann, J., Schneider, A. M., Gruska, I., Vetter, B., Thomas, D., Kießling, M., Wittmann, S., Herrmann, A., Schindler, M., Milbradt, J., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0529-z · Cited by 25
Fingolimod inhibits multiple stages of the HIV-1 life cycle
Resop, R. S., Fromentin, R., Newman, D., Rigsby, H., Dubrovsky, L., Bukrinsky, M., Chomont, N., & Bosque, A. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008679 · Cited by 25
“SAMHD1 was first shown to restrict HIV-1 in myeloid and dendritic cells [51] and was recently demonstrated to have an analogous role in macrophages [73–75] and CD4 T cells [76–78].”
BackgroundMechanisms of HIV-1 cell-to-cell transfer to myeloid cells
Han, M., Woottum, M., Mascarau, R., Vahlas, Z., Vérollet, C., & Bénichou, S. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0322-737r · Cited by 25
Tailored HIV-1 Vectors for Genetic Modification of Primary Human Dendritic Cells and Monocytes
Durand, S., Nguyen, X.-N., Turpin, J., Cordeil, S., Nazaret, N., Croze, S., Mahieux, R., Lachuer, J., Legras‐Lachuer, C., & Cimarelli, A. (2012) · Journal of Virology · doi:10.1128/jvi.01459-12 · Cited by 26
“A number of recent reports indicate that the cellular protein SAMHD1 specifies a major restriction during MDDC transduction by reducing the pool of intracellular nucleosides available for reverse transcription and indicate that Vpx relieves this restriction by degrading it (20, 21, 29, 37).”
BackgroundMetabolic pathways as regulators of HIV infection
Craveiro, M., Clerc, I., Sitbon, M., & Taylor, N. N. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835fc53e · Cited by 25
Nakayama, E. E., & Shioda, T. (2015) · AIDS · doi:10.1097/qad.0000000000000812 · Cited by 25
“The most recently identified host factor is SAMHD1 (a cellular protein sterile alpha motif and histidine/aspartic aciddomain containing protein), which is a dendritic and myeloid cell specific HIV-1 restriction factor counteracted by HIV-2/SIV Vpx [9,10].”
BackgroundHomeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation
Tsunetsugu‐Yokota, Y., Kobayashi‐Ishihara, M., Wada, Y., Terahara, K., Takeyama, H., Kawana‐Tachikawa, A., Tokunaga, K., Yamagishi, M., Martínez, J. P., & Meyerhans, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01944 · Cited by 25
“…activity observed in resting HSP cultured cells was correlated to an upregulation of the restriction factors SAMHD1 and/or APOBEC3G (Chiu et al., 2005; Laguette et al., 2011) we quantitated transcripts of these genes in the sorted GFP+ and GFP−/resting CD4+ T cells from three donors by qRT-PCR.”
BackgroundMethodInfluentialRoesch, F., OhAinle, M., & Emerman, M. (2018) · Retrovirology · doi:10.1186/s12977-018-0409-2 · Cited by 29
“SAMHD1 is a dNTP triphosphohydrolase that depletes the cellular pools of dNTPs [12] in quiescent cells of the myeloid lineage and in resting CD4 + T cells [13], resulting in a block to reverse transcription [10, 11].”
InfluentialHIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1
Ikeda, T., Molan, A. M., Jarvis, M. C., Carpenter, M. A., Salamango, D. J., Brown, W. L., & Harris, R. S. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001276 · Cited by 24
“The creation and characterization of the permissive T cell line SupT11 has been reported [19, 35].”
BackgroundToward a Macaque Model of HIV-1 Infection: Roadblocks, Progress, and Future Strategies
Thippeshappa, R., Kimata, J. T., & Kaushal, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00882 · Cited by 26
Single-cell analysis reveals divergent responses of human dendritic cells to the MVA vaccine
Döring, M., de Azevedo, K., Blanco-Rodriguez, G., Nadalin, F., Satoh, T., Gentili, M., Lahaye, X., Silva, N. S. D., Conrad, C., Jouve, M. J., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abd9720 · Cited by 26
The Prokaryotic Roots of Eukaryotic Immune Systems
Aravind, L., Nicastro, G. G., Iyer, L. M., & Burroughs, A. M. (2024) · Annual Review of Genetics · doi:10.1146/annurev-genet-111523-102448 · Cited by 23
Innate immunity in the control of HIV/AIDS
Ploquin, M. J.-Y., Jacquelin, B., Jochems, S. P., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2012) · AIDS · doi:10.1097/qad.0b013e328353e46b · Cited by 23
“specifically confined to differentiated uncycling cells like macrophages and mDC [37, 38].”
SAMHD1 is active in cycling cells permissive to HIV-1 infection
Badía, R., Pujantell, M., Torres‐Torronteras, J., Menéndez‐Arias, L., Martí, R., Ruzo, A., Pauls, E., Clotet, B., Ballana, E., Esté, J. A., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.03.019 · Cited by 23
Davenne, T., Klintman, J., Sharma, S., Rigby, R. E., Blest, H. T. W., Cursi, C., Bridgeman, A., Dadonaite, B., Keersmaecker, K. D., Hillmen, P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107640 · Cited by 24
Siddiqui, M. A., & Yamashita, M. (2021) · mBio · doi:10.1128/mbio.02817-21 · Cited by 24
“Trex1, a cellular exonuclease, degrades aborted viral DNA (15, 31, 59), while SamHD1 may limit the amount of viral DNA to a minimum (94, 95).”
BackgroundTrim69 is a microtubule regulator that acts as a pantropic viral inhibitor
Song, Y., Nguyen, X.-N., Kumar, A., da Silva, C., Picard, L., Etienne, L., & Cimarelli, A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211467119 · Cited by 24
“This is not unprecedented as other cellular factors inhibit HIV-1 in a cell-type-speci fi c manner [e.g., SAMHD1, or APOBEC3A (23, 24)].”
In vivo HIV-1 nuclear condensates safeguard against cGAS and license reverse transcription
Ay, S., Burlaud‐Gaillard, J., Gazi, A. D., Tatirovsky, E., Cuche, C., Diana, J., Scoca, V., Santo, J. P. D., Roingeard, P., Mammano, F., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00316-w · Cited by 25
“Interestingly, even in the presence of Vpx, which degrades the restriction factor SAMHD1 (Laguette et al, 2011) the HIV-1 capsid evades sensing of dsDNA before integration (Lahaye et al, 2018; Zuliani-Alvarez et al, 2022).”
Canine Hepacivirus NS3 Serine Protease Can Cleave the Human Adaptor Proteins MAVS and TRIF
Parera, M., Martrus, G., Franco, S., Clotet, B., & Martı́nez, M. Á. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042481 · Cited by 23
“Well-character- ized restriction factors are APOBEC3G [7], TRIM5-a proteins [8], tetherin (BST2) [9], and SAMHD1 [10,11], which inhibit human immunodeficiency virus (HIV) propagation at various steps in its replication cycle.”
BackgroundKobayashi, T., Takeuchi, J. S., Ren, F., Matsuda, K., Sato, K., Kimura, Y., Misawa, N., Yoshikawa, R., Nakano, Y., Yamada, E., et al. (2014) · Scientific Reports · doi:10.1038/srep05529 · Cited by 24
The druggability of intracellular nucleotide-degrading enzymes
Rampazzo, C., Tozzi, M. G., Dumontet, C., & Jordheim, L. P. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2921-6 · Cited by 23
Recent Advances in Lentiviral Vaccines for HIV-1 Infection
Norton, T. D., & Miller, E. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00243 · Cited by 26
“HIV-2 and some SIV isolates encode the accessory protein Vpx that counteracts this block to infection by binding to SAMHD1 and recruiting an E3 ubiquitin ligase complex, CRL4, to mediate its proteasomal degradation (48, 49).”
Sam Domains in Multiple Diseases
Vincenzi, M., Mercurio, F. A., & Leone, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181009114445 · Cited by 25
Qin, Z., Bonifati, S., Gelais, C. S., Li, T.-W., Kim, S., Antonucci, J. M., Mahboubi, B., Yount, J. S., Xiong, Y., Kim, B., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010360 · Cited by 23
“The Vpx protein from HIV-2 and Vpx/Vpr of certain lineages of simian immunodeficiency viruses target SAMHD1 for degradation through the ubiquitin proteasome pathway (9, 10, 18).”
BackgroundDaxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner
Maillet, S., Fernandez, J., Decourcelle, M., Koulali, K. E., Blanchet, F. P., Arhel, N. J., Maarifi, G., & Nisole, S. (2020) · Viruses · doi:10.3390/v12060636 · Cited by 26
“However, reverse transcription appears to be a hotspot for restriction, since it is targeted by several potent antiviral factors, including TRIM5α [8], APOBEC3G [4,9], and SAMHD1 [10,11].”
BackgroundThe SAM domain of mouse SAMHD1 is critical for its activation and regulation
Buzovetsky, O., Tang, C., Knecht, K. M., Antonucci, J. M., Wu, L. J., Ji, X., & Xiong, Y. (2018) · Nature Communications · doi:10.1038/s41467-017-02783-8 · Cited by 23
Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
Negri, D. R. M., Rossi, A., Blasi, M., Michelini, Z., Leone, P., Chiantore, M. V., Baroncelli, S., Perretta, G., Cimarelli, A., Klotman, M. E., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-69 · Cited by 24
“and could be explained by recent papers showing that SIV-Vpx interacts with SAMHD1, a HIV-1 restriction factor in myeloid cells, such as DC and macrophages, that inhibits an early step of the viral life cycle [21,22].”
BackgroundResultHIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels
Chauveau, L., Donahue, D. A., Monel, B., Porrot, F., Bruel, T., Richard, L., Casartelli, N., & Schwartz, O. (2017) · Journal of Virology · doi:10.1128/jvi.01248-17 · Cited by 30
“VLPs containing Vpx were produced using SIV-3 WT plasmids as described previously (13, 14).”
MethodSelf-citationWang, Z., Bhattacharya, A., White, T. E., Buffone, C., McCabe, A., Nguyen, L. A., Shepard, C., Pardo, S., Kim, B., Weintraub, S. T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.090 · Cited by 27
“…function, because SAMHD1 blocks retroviral replication before completion of reverse transcription (Fujita et al., 2008; Goujon et al., 2007; Laguette et al., 2011) and the SAMHD1-mediated decrease in the dinucleotide triphosphate (dNTP) levels in myeloid cells correlates with the inability…”
Chronic HIV Transcription, Translation, and Persistent Inflammation
Kilroy, J. M., Leal, A. A., & Henderson, A. J. (2024) · Viruses · doi:10.3390/v16050751 · Cited by 25
“It has been shown that Vpr induces the CRL4 DCAF E3-mediated ubiquitination and proteasomal degradation of DDR factors including CCDC137 [74], HLTF [72], UNG2 [72,75,76], MUS81/EME1 [36,77], EXO1 [78], TET2 [79], MCM10 [80] and components of the SLX4 complex [77,81].”
BackgroundPaludan, S. R., & Mogensen, T. H. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.05.004 · Cited by 22
Sertznig, H., Roesmann, F., Wilhelm, A., Heininger, D., Bleekmann, B., Elsner, C., Santiago, M. L., Schuhenn, J., Karakoese, Z., Benatzy, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935800 · Cited by 22
An overview of intracellular interactions between immunodeficiency viruses and their hosts
Bieniasz, P. D. (2012) · AIDS · doi:10.1097/qad.0b013e328353bd04 · Cited by 25
“Gag Matrix NMT(N-myristoyl transferase) Lipid modification of Gag-N-terminus PI [4,5]P2 (phosphatidylinositol 4,5-bisphosphate) Plasma membrane resident phospholipid that drives Gag targeting to the plasma membrane Capsid TRIM5a (tripartite motif-5a) Antiviral protein that targets incoming capsids TRIMCyp (TRIM5-CypA…”
BackgroundPerrin, S., Cremer, J., Roll, P., Zaegel‐Faucher, O., Menard, A., Reynes, J., Dellamonica, P., Naqvi, A., Micallef, J., Jouve, É., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041129 · Cited by 24
“HIV1 Vpx protein has been demonstrated to relieve replication restriction in monocytes [88] by inducing the proteasomal degradation of SAM domain and HD domain-containing protein 1 (SAMHD1), the HIV-1 restriction factor that is specific for myeloid lineage cells and is not expressed by lymphocytes [89].”
SAMHD1 Restricts HIV-1 Replication and Regulates Interferon Production in Mouse Myeloid Cells
Zhang, R., Bloch, N., Nguyen, L. A., Kim, B., & Landau, N. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089558 · Cited by 27
“Because HIV-1 lacks the Vpx packaging motif it does not package Vpx [21,22].”
BackgroundInfluentialHarper, M. S., Barrett, B. S., Smith, D. S., Li, S. X., Sutter, K., Dittmer, U., Hasenkrug, K. J., & Santiago, M. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202920 · Cited by 22
“HIV-1 in plasma (65), whereas restriction blocks because of another factor, SAMHD1, limit HIV-1 replication in myeloid cells (66, 67).”
BackgroundInnate immune cell responses in non pathogenic versus pathogenic SIV infections
Huot, N., Rascle, P., Garcia-Tellez, T., Jacquelin, B., & Müller-Trutwin, M. C. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.06.011 · Cited by 23
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.